SENTINEL LYMPH NODE BIOPSY USING METHYLENE BLUE DYE IN EARLY BREAST CANCER. IS IT TRULY RELIABLE?

Assessment of the efficacy and oncological safety of sentinel lymph node biopsy in node-negative breast cancer using methylene blue dye

Assessment of accuracy of axillary sentinel lymph node biopsy in medially located breast cancer using methylene blue injection technique: our institute experience

Evaluation of sentinel lymph node biopsy using 1% methylene blue in node-responsive postneoadjuvant chemotherapy in patients with breast cancer

Sentinel Lymph Node Biopsy in Early Breast Cancer Using Patent Blue Dye as a Single Identification Method: Experience of an Academic Center

Carbon nanoparticles versus patent blue dye for detection of sentinel lymph node in patients with early breast cancer

Evaluation of the Efficacy of Combined Sentinel Lymph Node Biopsy Using Patent Blue Dye and Peripheral Lymph Node Biopsy in Management of Nodal Negative Early Breast Cancer

SENTINEL LYMPH NODES DISSECTION VERSUS AXILLARY LYMPH NODES DISSECTION IN PATIENTS WITH EARLY BREAST CANCER AND SENTINEL NODES METASTASES

Indocyanine Green Fluorescence-Guided Sentinel Node Biopsy during Surgery for Breast Cancer

FROZEN SECTION EXAMINATION OF SENTINEL LYMPH NODE IN EARLY BREAST CANCER